Visit msnbc.com for breaking news, world news, and news about the economy
So you know that survey you get in the mail after a hospital stay or an outpatient diagnostic test? The one that ask you questions like, "Were you treated politely?" and "Were snacks available without having to ask for them?" Due to requirements in the new Obamacare federal health regulations, Medicare money for hospitals will to some degree be tied to patient satisfaction scores -- most of which will come from those post-encounter surveys. Check out this nice video from msnbc.
Showing posts with label hospitals. Show all posts
Showing posts with label hospitals. Show all posts
Sunday, November 27, 2011
Monday, March 7, 2011
Groupon: Are coupons really the right answer for health care?
I'm always fascinated by new technology and particularly ways social media works in our world.
So it was natural for me to sign up for Groupon.com, the internet based deal program that works with local vendors to offer special coupons and discounts for products or services.
Sometimes these deals are just incredible - from 50% off food products to half price golf to yoga for $19 per month rather than $140.
But what about using coupons for health care services?
Sounds odd, I know, but this has been a common practice for years with aesthetic services and cosmetic procedures or treatments.
It's not uncommon at all to see deals for "free Botox" or discounts on micro-dermabrasion or chemical peels.
But would you be influenced by a coupon for "free prostate exam" or "buy one get one free mammogram"? Or would you just think that provider was weird?
It may sounds strange, but actually this happens every day.
It's hidden behind the cloak and dagger world of the pharmaceutical sample closet.
For years the drug sample has been the easiest tease to entice patients to try a different medication. Sometimes they are very helpful -- a difficult medication to use (like an unusual dispenser for a spray on product), unusual side effects ("try it before you buy it"), or most commonly the patient has no money and they leave with a bag full of free drugs.
But these are certainly short term solutions and may or may not lead to a patient actually buying the product.
It's no surprise that most of the samples in the closet are for chronic medications -- not for something you have to take for a week or less.
But the interesting invasion into the sample closet has been the coupon.
Now not quite "groupon-like," coupons are now available for almost all name brand, non-generic medications -- particularly if they are early in their evolution of release.
This is how it usually works: you decide you want to prescribe a new anti-hypertensive (an expensive way to say blood pressure medication). Compared to a generic medicine which might fall under the $4 per month Walmart plan, this medication might be $300 per month.
But, there might be some advantages: lower incidence of side effects, easier dosing regimen, or maybe its more effective. There usually is a real medical reason despite what some Washington pundits might say.
Newer drugs usually work better.
But, nevertheless it costs $300. That's roughly half of some people's Social Security check.
Now with insurance this medication would be a lot cheaper (for the patient) but it is very likely that it would not fall under the "preferred plan" of their prescription drug coverage.
That means that it would likely cause a higher co-pay such as $50 as opposed to $5.
This is where the pharmaceutical coupons come into play. Now, instead of advertisement laden boxes of pills, the sample closet is full of boxes full of coupons or discount cards.
Patients are asked to call a 1-800 number to activate the card, "register" (which means the company collects information on the patient, disease, and provider), and then the card can be used to off set part of the extra cost related to use of the expensive medication.
These cards usually function as "discount cards." That is, they will provide either a certain reduction in your copay amount, or they will fix the total cost of medication at a certain point.
Most of the cards require you have insurance to use them. There is no free lunch here, and the drug companies themselves don't want to be out the total cost of the drug, only part of their margin.
Sometimes there are limits on the amount of benefit you can receive. The card may only be good for three refills, or it may be unlimited. You want to make sure you check this carefully before you continue to refill your medication.
Pharmacies as rule don't like to deal with these cards. Much like grocery stores don't like to deal with coupons.
There is an extra step for them, possibly some activation required on their part and certainly they have to carry additional float, in addition to your insurance, before they will get paid.
What's fascinating to me is that these provide a direct incentive to use a more expensive medication.
Now, as I've outlined here, there are some benefits of these cards. But let's face it, these are expensive medications -- there is no free lunch.
It's the incentive that seems bizarre. Physicians and hospitals are forbidden from discounting co-pays, not collecting deductibles, or for offering covered services for less than the contracted amount in most insurance contracts.
There have been several lawsuits already between rival health care systems in communities where one hospital might write off co-pays or deductibles to entice patients to choose their facility over the competitor.
This might be like a patient knowing that regardless if he has Blue Cross Blue Shield insurance, for example, they could choose either emergency room -- because the cost would be the same to them.
Patients with high deductible insurance plans are particularly susceptible to this type of gaming. The catch is that the hospital is able to collect enough money on the subsequent procedure or test to offset the loss of the deductible.
The problem is for the insurance company and the other insured patients that are on the policy.
It removes the incentive to stay within network and comply with the contract that makes indemnity insurance work in the first place.
Everyone has to play by the same rules.
So why do pharmaceutical companies get to use these discount cards?
I'm not sure I can answer that question, but I hope I've been able to shed some light on these type of cards and discounts.
In some situations they may be very helpful. If you require an expensive medication, particularly one that is new, be sure to ask your physician if the company offers any type of discount card.
If not, then asked them for a lower priced, generic alternative.
Otherwise, just be aware that these cards can get you established on an expensive medicine for you only to find out that the benefits were temporary.
Also be careful if the company is going to send you a rebate. This puts the risk on you for collecting the money.
So although not quite Groupon.com type coupons, there are some discounts available for expensive medications.
You just may have to shop around and be an educated consumer-patient.
So it was natural for me to sign up for Groupon.com, the internet based deal program that works with local vendors to offer special coupons and discounts for products or services.
Sometimes these deals are just incredible - from 50% off food products to half price golf to yoga for $19 per month rather than $140.
But what about using coupons for health care services?
Sounds odd, I know, but this has been a common practice for years with aesthetic services and cosmetic procedures or treatments.
It's not uncommon at all to see deals for "free Botox" or discounts on micro-dermabrasion or chemical peels.
But would you be influenced by a coupon for "free prostate exam" or "buy one get one free mammogram"? Or would you just think that provider was weird?
It may sounds strange, but actually this happens every day.
It's hidden behind the cloak and dagger world of the pharmaceutical sample closet.
For years the drug sample has been the easiest tease to entice patients to try a different medication. Sometimes they are very helpful -- a difficult medication to use (like an unusual dispenser for a spray on product), unusual side effects ("try it before you buy it"), or most commonly the patient has no money and they leave with a bag full of free drugs.
But these are certainly short term solutions and may or may not lead to a patient actually buying the product.
It's no surprise that most of the samples in the closet are for chronic medications -- not for something you have to take for a week or less.
But the interesting invasion into the sample closet has been the coupon.
Now not quite "groupon-like," coupons are now available for almost all name brand, non-generic medications -- particularly if they are early in their evolution of release.
This is how it usually works: you decide you want to prescribe a new anti-hypertensive (an expensive way to say blood pressure medication). Compared to a generic medicine which might fall under the $4 per month Walmart plan, this medication might be $300 per month.
But, there might be some advantages: lower incidence of side effects, easier dosing regimen, or maybe its more effective. There usually is a real medical reason despite what some Washington pundits might say.
Newer drugs usually work better.
But, nevertheless it costs $300. That's roughly half of some people's Social Security check.
Now with insurance this medication would be a lot cheaper (for the patient) but it is very likely that it would not fall under the "preferred plan" of their prescription drug coverage.
That means that it would likely cause a higher co-pay such as $50 as opposed to $5.
This is where the pharmaceutical coupons come into play. Now, instead of advertisement laden boxes of pills, the sample closet is full of boxes full of coupons or discount cards.
Patients are asked to call a 1-800 number to activate the card, "register" (which means the company collects information on the patient, disease, and provider), and then the card can be used to off set part of the extra cost related to use of the expensive medication.
These cards usually function as "discount cards." That is, they will provide either a certain reduction in your copay amount, or they will fix the total cost of medication at a certain point.
Most of the cards require you have insurance to use them. There is no free lunch here, and the drug companies themselves don't want to be out the total cost of the drug, only part of their margin.
Sometimes there are limits on the amount of benefit you can receive. The card may only be good for three refills, or it may be unlimited. You want to make sure you check this carefully before you continue to refill your medication.
Pharmacies as rule don't like to deal with these cards. Much like grocery stores don't like to deal with coupons.
There is an extra step for them, possibly some activation required on their part and certainly they have to carry additional float, in addition to your insurance, before they will get paid.
What's fascinating to me is that these provide a direct incentive to use a more expensive medication.
Now, as I've outlined here, there are some benefits of these cards. But let's face it, these are expensive medications -- there is no free lunch.
It's the incentive that seems bizarre. Physicians and hospitals are forbidden from discounting co-pays, not collecting deductibles, or for offering covered services for less than the contracted amount in most insurance contracts.
There have been several lawsuits already between rival health care systems in communities where one hospital might write off co-pays or deductibles to entice patients to choose their facility over the competitor.
This might be like a patient knowing that regardless if he has Blue Cross Blue Shield insurance, for example, they could choose either emergency room -- because the cost would be the same to them.
Patients with high deductible insurance plans are particularly susceptible to this type of gaming. The catch is that the hospital is able to collect enough money on the subsequent procedure or test to offset the loss of the deductible.
The problem is for the insurance company and the other insured patients that are on the policy.
It removes the incentive to stay within network and comply with the contract that makes indemnity insurance work in the first place.
Everyone has to play by the same rules.
So why do pharmaceutical companies get to use these discount cards?
I'm not sure I can answer that question, but I hope I've been able to shed some light on these type of cards and discounts.
In some situations they may be very helpful. If you require an expensive medication, particularly one that is new, be sure to ask your physician if the company offers any type of discount card.
If not, then asked them for a lower priced, generic alternative.
Otherwise, just be aware that these cards can get you established on an expensive medicine for you only to find out that the benefits were temporary.
Also be careful if the company is going to send you a rebate. This puts the risk on you for collecting the money.
So although not quite Groupon.com type coupons, there are some discounts available for expensive medications.
You just may have to shop around and be an educated consumer-patient.
Friday, December 3, 2010
The Health Care Cold War: Will ACO's Bring Down The Wall?
Although there are no sounds of B-52's flying at low altitudes above the hospital, there are salvos nonetheless between the partners in health care as the positioning of providers in the ACO marketplace starts to crystallize.
ACO's, or accountable care organizations, are the product of one of the Obamacare beta solutions for controlling health care costs and improving outcomes.
My friend Dan Finch at the Texas Medical Association compared them to unicorns: no one's ever seen one but you'll recognize it when you do.
I'm not sure he's completely correct, there are a few of these organizations forming around the country. One in Chicago offers to produce great data on the utility of the delivery mechanism though the jury is still out on whether it will net positive results for patients.
These new entities can be formed really by anyone -- that is, anyone brave enough to pioneer the business model. The risks are great because of the capital requirements to protect the integrity of the captitated payment system which is really the heart of the organization.
Capitation is an ugly word in health care financing probably because of the almost unanimous negative consequences of the insurance models funded in this manner in the 90's.
Everyone then left with a bad taste in their mouth.
Insurance companies couldn't rein in physicians and hospitals to control costs and patients never bought into the model that prevented them from using a infinite amount of resources in their own health care.
So why would it be different now?
The argument is mostly supported not by the change in patient expectations or the robust IT infrastructure that we have in this century, but rather by the necessity to control costs. That argument unfortunately will drive the business principles that formulate these new organizations.
The definition of a "cold war" must include the word "protectionism." Certainly the world saw the escalation in missile batteries and nuclear warheads until Reagan was successful in "tearing down that wall."
But, pardon the reckless use of the 1988-presidential-debate line: Mr. Obama you are no Reagan.
Why am I so pessimistic these ACO's will find a place in this market space?
First is the lack of a unified national standard concerning our information technology infrastructure. There is currently no data sharing among providers outside of their own controlled groups (you can thank another federal stature for the difficulty here: read HIPPA).
And although a standard can be created and implemented, there is still the fact that many of the ground war health care practitioners (the primary care physicians) are still not active users of this technology. Current estimates put this at somewhere around 30% tops.
And with the cost of implementation of an electronic health record setup in a physician's office near $40K it will be some time before we see widespread adoption of EMR's.
Then there is the issue of exactly what we will measure to insure that quality care is being delivered. These so called "measures" of quality are still undergoing national debate and peer review. They're close to getting the numbers right. The question is whether physicians and patients will buy in.
And finally there is the nasty issue of "gain sharing." This is where you reward the parties for achieving the goals of delivering high quality care in an efficient manner.
Paying physicians is particularly difficult because of a myriad of other federal statues relating to anti-trust and kick back regulations.
Some groups, particularly hospitals, believe that the answer to this issue is direct employment of physicians. But this business model is challenging in that not only must a hospital control the diverse interests of a multi-specialty group of physicians, but it also has to morph the health care of individual patients to fit a cost savings model.
Both of these groups are not historically responsive to direction by a third party.
Then you have the difficult problem that hospitals are funded by actually admitting patients and providing care. In the ACO model the profits only come from keeping patient's healthy and OUT OF THE HOSPITAL.
Now sure, business models can change. But hospitals will have to recognize and be able to adapt to this change in a swift and controlled manner to insure that they remain profitable and can continue their mission.
Oh lest I forget one other very important party to the ACO equation: the people who pay for health care services.
Whether these ACO's are created as a hospital-based entity or along the traditional insurance model, at the end of the day both the government and American business expect to pay less for health care services in the future.
So for the ACO model to be successful it actually has to have a declining net revenue line.
It is this money line that has everyone so concerned and lining up to protect their own interests.
Hospitals are arguing for a hospital-centric model so they can control the dollar at the end of the day. Physicians are either jumping on board with the hospital groups or they are lobbying for measures to protect their private practice.
Patient groups are seeing that there could be limitations on both who they can see for care and where they can go. This loss of autonomy in the doctor-patient relationship will be very hard for most patients to swallow.
Insurance companies and business groups don't trust hospitals, physicians, or patients to work to control costs in the health care economy. So they are lobbying for strong protective measures to insure that ACO's don't get out of the normal reserve requirements to sell an insurance product.
ACO's hold the promise of ending the cold war.
If all of the parties could work together on a fair and balanced model that puts the patient first in the decision making process, it could offer an opportunity for success.
But for now all of the parties are building up their arms to protect their own interests, or they are being overwhelmed by a well funded adversary.
Virtually every hospital is "creating an ACO" and physician's practices are being gobbled up health care systems.
I applaud the idea of collaboration and use of IT to improve the health experience for patients. Today, though, I'm not too confident that the current attempt at tearing down the wall will work.
- Posted using BlogPress from my iPad
ACO's, or accountable care organizations, are the product of one of the Obamacare beta solutions for controlling health care costs and improving outcomes.
My friend Dan Finch at the Texas Medical Association compared them to unicorns: no one's ever seen one but you'll recognize it when you do.
I'm not sure he's completely correct, there are a few of these organizations forming around the country. One in Chicago offers to produce great data on the utility of the delivery mechanism though the jury is still out on whether it will net positive results for patients.
These new entities can be formed really by anyone -- that is, anyone brave enough to pioneer the business model. The risks are great because of the capital requirements to protect the integrity of the captitated payment system which is really the heart of the organization.
Capitation is an ugly word in health care financing probably because of the almost unanimous negative consequences of the insurance models funded in this manner in the 90's.
Everyone then left with a bad taste in their mouth.
Insurance companies couldn't rein in physicians and hospitals to control costs and patients never bought into the model that prevented them from using a infinite amount of resources in their own health care.
So why would it be different now?
The argument is mostly supported not by the change in patient expectations or the robust IT infrastructure that we have in this century, but rather by the necessity to control costs. That argument unfortunately will drive the business principles that formulate these new organizations.
The definition of a "cold war" must include the word "protectionism." Certainly the world saw the escalation in missile batteries and nuclear warheads until Reagan was successful in "tearing down that wall."
But, pardon the reckless use of the 1988-presidential-debate line: Mr. Obama you are no Reagan.
Why am I so pessimistic these ACO's will find a place in this market space?
First is the lack of a unified national standard concerning our information technology infrastructure. There is currently no data sharing among providers outside of their own controlled groups (you can thank another federal stature for the difficulty here: read HIPPA).
And although a standard can be created and implemented, there is still the fact that many of the ground war health care practitioners (the primary care physicians) are still not active users of this technology. Current estimates put this at somewhere around 30% tops.
And with the cost of implementation of an electronic health record setup in a physician's office near $40K it will be some time before we see widespread adoption of EMR's.
Then there is the issue of exactly what we will measure to insure that quality care is being delivered. These so called "measures" of quality are still undergoing national debate and peer review. They're close to getting the numbers right. The question is whether physicians and patients will buy in.
And finally there is the nasty issue of "gain sharing." This is where you reward the parties for achieving the goals of delivering high quality care in an efficient manner.
Paying physicians is particularly difficult because of a myriad of other federal statues relating to anti-trust and kick back regulations.
Some groups, particularly hospitals, believe that the answer to this issue is direct employment of physicians. But this business model is challenging in that not only must a hospital control the diverse interests of a multi-specialty group of physicians, but it also has to morph the health care of individual patients to fit a cost savings model.
Both of these groups are not historically responsive to direction by a third party.
Then you have the difficult problem that hospitals are funded by actually admitting patients and providing care. In the ACO model the profits only come from keeping patient's healthy and OUT OF THE HOSPITAL.
Now sure, business models can change. But hospitals will have to recognize and be able to adapt to this change in a swift and controlled manner to insure that they remain profitable and can continue their mission.
Oh lest I forget one other very important party to the ACO equation: the people who pay for health care services.
Whether these ACO's are created as a hospital-based entity or along the traditional insurance model, at the end of the day both the government and American business expect to pay less for health care services in the future.
So for the ACO model to be successful it actually has to have a declining net revenue line.
It is this money line that has everyone so concerned and lining up to protect their own interests.
Hospitals are arguing for a hospital-centric model so they can control the dollar at the end of the day. Physicians are either jumping on board with the hospital groups or they are lobbying for measures to protect their private practice.
Patient groups are seeing that there could be limitations on both who they can see for care and where they can go. This loss of autonomy in the doctor-patient relationship will be very hard for most patients to swallow.
Insurance companies and business groups don't trust hospitals, physicians, or patients to work to control costs in the health care economy. So they are lobbying for strong protective measures to insure that ACO's don't get out of the normal reserve requirements to sell an insurance product.
ACO's hold the promise of ending the cold war.
If all of the parties could work together on a fair and balanced model that puts the patient first in the decision making process, it could offer an opportunity for success.
But for now all of the parties are building up their arms to protect their own interests, or they are being overwhelmed by a well funded adversary.
Virtually every hospital is "creating an ACO" and physician's practices are being gobbled up health care systems.
I applaud the idea of collaboration and use of IT to improve the health experience for patients. Today, though, I'm not too confident that the current attempt at tearing down the wall will work.
- Posted using BlogPress from my iPad
Location:Quito, Ecuador
Subscribe to:
Posts (Atom)